OxyContin maker Purdue Pharma reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its settlement offer in bankruptcy proceedings starting as soon as next week, people familiar with the matter said. Jillian Kitchener reports.

general info

  • Uploaded    09/11/2019
  • Business & Finance
  • FDJ shares surge in French lottery group's market debut
  • Thyssenkrupp scraps dividend as pain continues
  • Macy's slashes outlook second time before holidays
  • Survey: Millennials Expect To Be Permanent Renters
  • Walmart To Open 500 New Stores In China
  • Verizon Offers Official 5G Maps
  • Lyon welcomes Beaujolais Nouveau under shadow of U.S. tariffs
  • Apple CEO Tim Cook Talks About Internet Privacy
  • Trump considers Apple exemption from China tariffs